Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human His6-Miro1/Rhot1 Protein, Carrier-free Available on GSA/VA Contract for Federal Government customers only.

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Manufacturer:  R&D Systems™ SP490100

Catalog No. SP490100


Add to cart
This item is not returnable. View return policy

Description

Description

The Recombinant Human His6-Miro1/Rhot1 Protein is derived from E. coli. The Recombinant Human His6-Miro1/Rhot1 Protein has been validated for the following applications: Bioactivity.

This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.

Order Info

The product is shipped with dry ice or equivalent.

Specifications

Specifications

Q8IXI2
Xmg/mL (XμM) in 50mM HEPES pH 8.0, 200mM NaCl, 10% (v/v) Glycerol, 2mM TCEP
50 kDa
>90%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie Blue stain.
E. coli
RUO
Unconjugated
Yes
Bioactivity
55288
ARHT1, EC 3.6.5, EC 3.6.5.-, FLJ11040, FLJ12633, hMiro-1, MIRO-1mitochondrial Rho GTPase 1, mitochondrial Rho 1, rac-GTP binding protein-like protein, Rac-GTP-binding protein-like protein, Ras homolog gene family member T1, ras homolog gene family, member
100μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -70° C as supplied. 3 months, -70° C under sterile conditions after opening.
Measured in an anti-viral assay using HepG2 human hepatocellular carcinoma cells infected with encephalomyocarditis (EMC) virus. Sheppard, P. et al. (2003) Nat. Immunol. 4:63. The ED50 for this effect is 0.2-1.2 μg/mL.
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

For Research Use Only